Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients

Autor: R Bataille, BG Durie, J Sany, SE Salmon

Publikováno v: Blood. 55:802-805

Acid phosphatase (AP) activity of plasma cells was studied in 38 patients with multiple myeloma (MM). The average activity per cell was strong (mean score = 2.42; maximum score = 4) and the percentage of positive cells was greater than 90% in over 71

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::58e82a3ddd96383a0a0a5275cc58e304
https://doi.org/10.1182/blood.v55.5.802.bloodjournal555802

Phenotypic analysis of human myeloma cell lines

Autor: François Favier, BG Durie, Jean Brochier, Philippe Poncelet, Michel Jourdan, Christophe Duperray, Xue Guang Zhang, G Lenoir, Bernard Klein, C Vincent

Publikováno v: Europe PubMed Central

Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation, primarily in bone marrow, of a clone of plasma cells. The nature of the stem cells feeding the tumoral compartment is still unknown. To investigate this special point, we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617785094c328cf1be97be71dd8f9435
https://pubmed.ncbi.nlm.nih.gov/2537114

Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein

Autor: Ws, Dalton, Bg, Durie, Ds, Alberts, Jh, Gerlach, Anne Cress

Publikováno v: Europe PubMed Central

Multiple myeloma is a disease with a high initial chemotherapeutic response but virtually no cures due to emergence of drug resistance. A doxorubicin-resistant human myeloma cell line (8226/Dox) has been selected from the myeloma cell line RPMI8226 b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b6c7403705531ab7f0fb4ae424304877
https://pubmed.ncbi.nlm.nih.gov/2875788

Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity

Autor: BW Dana, BG Durie, RF White, DW Huestis

Publikováno v: Blood. 57(1)

One hundred and ninety-five series of granulocyte transfusions in 144 patients were evaluated with respect to possible severe pulmonary toxicity from concomitant administration of granulocytes and amphotericin B. Dyspnea as a side effect of granulocy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d251002a391380e41573e4118402a6
https://pubmed.ncbi.nlm.nih.gov/7004533

Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia.

Autor: Sharma D; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA., Ungar B; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA., Adalsteinsson JA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA. jonas.adalsteinsson@mountsinai.org., Sigurdsson JK; University of Iceland, Reykjavik, Iceland., Sharp K; Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, USA., Thorsteinsdóttir S; University of Iceland, Reykjavik, Iceland.; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Rögnvaldsson S; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Þórðardóttir ÁR; University of Iceland, Reykjavik, Iceland., Viðarsson B; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Önundarson PT; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Agnarssond BA; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Sigurðardóttird M; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Þorsteinsdóttir I; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Ólafsson Í; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Eyþórsson E; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Jónsson Á; Akureyri Hospital, Akureyri, Iceland., Ólafsson A; University of Iceland, Reykjavik, Iceland., Gíslason GK; University of Iceland, Reykjavik, Iceland., Landgren O; Myeloma Program, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA., Hulcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Durie BG; Cedars-Sinai Outpatient Cancer Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA., Harding S; Binding Site Group Ltd, Birmingham, UK., Love TJ; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Kristinsson SY; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.

Publikováno v: Archives of dermatological research [Arch Dermatol Res] 2024 Sep 14; Vol. 316 (9), pp. 627. Date of Electronic Publication: 2024 Sep 14.